128
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Aspartate aminotransferase to platelet ratio index – a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues

, , , , &
Pages 133-142 | Received 25 Jun 2015, Accepted 23 Nov 2015, Published online: 16 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Liguo Wang, Peng Chen & Chao Zheng. (2018) Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B. Infection and Drug Resistance 11, pages 2179-2185.
Read now

Articles from other publishers (10)

Na-Ling Kang, Jie-Min Zhang, Yu-Rui Liu, Su Lin, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu & Da-Wu Zeng. (2020) Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection. Clinics and Research in Hepatology and Gastroenterology 44:1, pages 57-65.
Crossref
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem & El-Sayed A. Wasfy. (2019) Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance. The Open Biomarkers Journal 9:1, pages 70-78.
Crossref
Jing Sun, Yanfang Li, Xuying Sun, Youde Liu, Danxia Zheng & Lijuan Fan. (2019) Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. Experimental and Therapeutic Medicine.
Crossref
Jing Sun, Yanfang Li, Xuying Sun, Hong Yu & Youde Liu. (2018) Dynamic Changes of the Aspartate Aminotransferase‐to‐Platelet Ratio and Transient Elastography in Predicting a Histologic Response in Patients With Chronic Hepatitis B After Entecavir Treatment. Journal of Ultrasound in Medicine 38:6, pages 1441-1448.
Crossref
Pallavi Surana, Devika Kapuria, Carly Broadwell, Elizabeth C. Wright, Varun Takyar, David E. Kleiner, Marc G. Ghany, Gil Ben-Yakov, Theo Heller, T. Jake Liang & Christopher Koh. (2019) Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years. Antiviral Research.
Crossref
Hongli Zhao, Xiangxin Song, Zhang Li & Xinling Wang. (2018) Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus. Medicine 97:37, pages e12356.
Crossref
Mingxiao Zhang, Xiaosong Hu, Shuai Li, Chen Lu, Juan Li, Yonghua Zong, Wenqian Qi & Huijun Yang. (2018) Hepatoprotective effects of ethyl pyruvate against CCl4-induced hepatic fibrosis via inhibition of TLR4/NF-κB signaling and up-regulation of MMPs/TIMPs ratio. Clinics and Research in Hepatology and Gastroenterology 42:1, pages 72-81.
Crossref
Guo-Dong Gao, Bo Sun, Xian-Bin Wang & Shi-Meng Wang. (2017) Neutrophil to Lymphocyte Ratio as Prognostic Indicator for Patients with Esophageal Squamous Cell Cancer. The International Journal of Biological Markers 32:4, pages 409-414.
Crossref
Dexin Wang, Ping Zhang & Min Zhang. (2017) Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase. Experimental and Therapeutic Medicine.
Crossref
Hongjie Ou, Shaohang Cai, Ying Liu, Muye Xia & Jie Peng. (2016) A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B. Therapeutic Advances in Gastroenterology 10:2, pages 207-217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.